BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36156030)

  • 1. [Panel Discussion - Problems in the Cancer Genomic Medicine].
    Ishioka C; Muto M; Yachida S; Shirota H; Hirasawa A; Miyagawa K; Ashizawa K; Kinoshita I; Nishihara H; Matsuura N; Sakurai A
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1014-1017. PubMed ID: 36156030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
    Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of the Cancer Genomic Medicine in the Tohoku District-Activity of Tohoku University Hospital as the Cancer Genome Medicine Core Base Hospital in Japan].
    Ishioka C
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):878-881. PubMed ID: 34267020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expert Panel Issues in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):991-993. PubMed ID: 36156022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Nishida T
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1223-1227. PubMed ID: 30237359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Sunami K
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Issues of Equalization of Cancer Genomic Medicine-Focusing on the Current Status in Nagasaki Prefecture].
    Ashizawa K; Udo E; Soda M; Furusato B
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1005-1007. PubMed ID: 36156027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and implementation of Cancer Genomic Medicine in Japan.
    Mukai Y; Ueno H
    Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer genomic medicine in Japan.
    Mano H
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(7):316-321. PubMed ID: 32788553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of Cancer Genomic Medicine in Kyushu Region and the Roles of Kyushu University Hospital as a Core Hospital for Cancer Genomic Medicine].
    Ito M; Baba E
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):873-877. PubMed ID: 34267019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interinstitutional Collaboration for Molecular Tumor Boards].
    Komine K; Shirota H
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):626-629. PubMed ID: 31164497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer genomic medicine in Japan and the roles of pharmacists.
    Aomori T; Sakurai H; Nishihara H
    Pharmacogenet Genomics; 2022 Aug; 32(6):242-245. PubMed ID: 35696282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
    Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H
    Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cooperative Tasks among Cancer Genome Medicine Facilities].
    Shirota H
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):997-999. PubMed ID: 36156024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects and Problems of Cancer Genome Analysis for Establishing Cancer Precision Medicine.
    Hayashi T; Konishi I
    Cancer Invest; 2019; 37(9):427-431. PubMed ID: 31451055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine.
    Hatanaka Y; Kuwata T; Morii E; Kanai Y; Ichikawa H; Kubo T; Hatanaka KC; Sakai K; Nishio K; Fujii S; Okamoto W; Yoshino T; Ochiai A; Oda Y
    Pathol Int; 2021 Nov; 71(11):725-740. PubMed ID: 34614280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Precision Medicine Provided by National Health Insurance].
    Muto M; Kondo T; Matsubara J; Kanai M; Matsumoto S; Ashida K; Suga J; Mukai K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1158-1163. PubMed ID: 32829347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Overview of Clinical Application of Whole Genome Analysis for Cancer].
    Fukada I
    Gan To Kagaku Ryoho; 2024 Jan; 51(1):7-13. PubMed ID: 38247084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidisciplinary Collaboration and Education Program Required for Equalization of Cancer Genomic Medicine].
    Miyagawa K
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1002-1004. PubMed ID: 36156026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.